Co-Director of WHRI / Professor of Vascular Pharmacology
Amrita Ahluwalia obtained a BSc in Pharmacology from Bath University and undertook doctoral training at the William Harvey Research Institute. In the mid-nineties she worked at St George's Hospital Medical School followed by University College London as a Lecturer before returning to the William Harvey where she is currently a Professor of Vascular Pharmacology. As well as her interests in the cardiovascular system she is committed to establishing gender-equality in the work place. Amrita established the first National mentoring scheme for women of a learned society (British Pharmacological Society) in 2005. She was also the first Chair of the Women in Pharmacology Committee of the same society from 2007-2010 that established the Astra Zeneca Women in Pharmacology Prize.
Summary of Research
Vascular Pharmacology Group
The main research focus of the group is the exploration of the investigation of the impact of inflammation on cardiovascular function and the mechanisms involved in this phenomenon. The group has 4 key areas of interest:
Effects of nitrite and nitrate on the cardiovascular system in health and disease
A major research focus of the group is study of the bioactivity of the reductive nitrate-to nitrite to NO pathway in humans, often dubbed the enterosalivary circuit of inorganic nitrate. We made the first demonstrations of the protective effects of inorganic nitrite against myocardial ischemia-reperfusion injury implicating two enzymes in the conversion of nitrite to NO: xanthine oxidoreductase and eNOS. More recently, the vasodilator activity of nitrite has attracted much attention. In 2008 we published our findings that a dietary nitrate load, in the form of beetroot juice, reduces blood pressure and improves platelet and endothelial function in healthy volunteers. We are currently investigating the effect of a similar inorganic nitrate load in hypertensive and hypercholesterolemic patients and with Anthony Mathur the potential of intracoronary nitrite in patients suffering an acute myocardial infarction.
Role of the kinin B1 receptor in cardiovascular disease
Ahluwalia & Perretti in 1996 published findings demonstrating the key role of the inducible kinin B1 receptor in neutrophil recruitment to a site of inflammation. Our research has focussed on the molecular pathways involved in this response and we have identified two particular pathways that play a role i.e. B1-induced endothelial chemokine generation and sensory C-fibre activation. Our most recent studies have demonstrated that laminar shear stress plays a major role in regulating endothelial kinin B1 receptor expression and that this regulation implicates the receptor in atherosclerosis.
Sex differences in cardiovascular function and susceptibility to cardiovascular disease
In 2005 Ahluwalia and Hobbs published the findings demonstrating that endothelium-dependent relaxation of the resistance arteries of females is predominantly mediated by the endothelial factor endothelium-derived hyperpolarising factor, EDHF, whereas in the resistance vessels of males NO and the prostaglandin PGI2 are the primary endothelial factors. We also demonstrated that this propensity to express EDHF protected females from genetically-induced hypertension and protects females from inflammation. We have speculated that these differences may have a role to play in the reduced susceptibility of females to cardiovascular disease. We are currently investigating the pathways involved in this sex-specific upregulation of EDHF and reduced inflammatory responses in healthy volunteers to determine the relevance of our findings in pre-clinical models to humans.
Investigation of the role of TRPV1 in vascular reactivity
In 2004 we identified a major role for the TRPV1 channel and sensory C-fibres in mediating the constriction of resistance arteries that occurs in response to rises in intraluminal pressure; termed myogenic tone. We are currently investigating the molecular pathways involved in this response, in particular our observations have identified the arachidonate metabolite 20-hydroxyeicoasteraenois acid as an important TRPV1 activator.
Dietary nitrate in the form of beetroot juice lowers blood pressure in healthy volunteers.
Within the blood vessel nitrite conversion to NO increases progressively with decreasing pH and oxygen tension. Our evidence suggests that both eNOS and xanthine oxidoreductase (XOR) are two key enzymes that act as nitrate reductases and are localised to both the endothelium and the red blood cell.
Members of the Group
Research staff: Dan Jones, Gianmichele Massimo, Vikas Kapil, Rayomand
Khambata, Amy Robertson, Sven van Eijl
PhD students: Federica Filomena, Sascha Hamers, Lorna Gee, Krishnaraj Rathod
For a full list of publist publications click here
Kristen J Bubb, Catherine Panayiotou, Hairuo Wen, Michaela Finsterbusch, Melissa Chan, John V Priestley, Mark D Baker & Amrita Ahluwalia. Activation of neuronal transient receptor potential vanilloid 1 (TRPV1) channel underlies 20-HETE-induced vasoactivity: role for protein kinase A. Hypertension 2013, 62(2):426-33.
Suborno M Ghosh, Vikas Kapil, Isabel Fuentes-Calvo, Kristen J Bubb, Vanessa Pearl, Alexandra B Milsom, Rayomand Khambata, Sheiva Maleki-Toyserkani, Mubeen Yousuf, Nigel Benjamin, Andrew J Webb, Mark J Caulfield, Adrian J Hobbs, Amrita Ahluwalia. Enhanced vasodilator activity of nitrite in hypertension: critical role for erythrocytic xanthine oxidoreductase and translational potential. Hypertension 2013 61(5):1091-102.
Anthony Rousselle,Fatimunnisa Qadri,Lisa Leukel, Rustem Yilmaz, Jean-Fred Fontaine, Gabin Sihn, Michael Bader, Amrita Ahluwalia, Johan Duchene. Cxcl5 limits macrophage foam cell formation in atherosclerosis. J Clin Invest 2013, 123(3):1343-7.
Vikas Kapil, Syed MA.Haydar, Vanessa Pearl, Jon O Lundberg, Eddie Weitzberg, Amrita Ahluwalia. Physiological role for nitrate-reducing oral bacteria in blood pressure control. Free Radic Biol Med. 2012, 55C:93-100
Hairuo Wen PhD, Kristen J Bubb PhD, Catherine Panayiotou PhD, Johan Östman PhD, John V Priestley PhD, Mark D Baker PhD & Amrita Ahluwalia PhD. 20-HETE is a novel activator of TRPV1. J Biol Chem, 2012, 287(17):13868-76.
Reshma S Baliga, Alex B Milsom, Sarah L Trinder, Suborno M Ghosh, Raymond J MacAllister,*Amrita Ahluwalia PhD & *Adrian J Hobbs. Dietary nitrate prevents hypoxic pulmonary hypertension: cytoprotective role for endothelial nitric oxide synthase. Circulation 2012, 125(23):2922-32
Inmaculada C Villar, Ramona S Scotland, Rayomand S Khambata, Melissa V Chan, Johan Duchene, Andre L Sampaio, Mauro Perretti, Adrian J Hobbs, Amrita Ahluwalia. Suppression of Endothelial P-Selectin Expression Contributes to Reduced Cell Trafficking in Females: An Effect Independent of NO and Prostacyclin. Arterioscler Thromb Vasc Biol. 2011, 31:1075-83.
Ramona Scotland, Melanie Madhani, Salvador Moncada, Adrian J.Hobbs & Amrita Ahluwalia. Endothelial nitric oxide synthase/cyclooxygenase-1 double knockout mice reveal cardioprotective role for endothelium-derived hyperpolarizing factor. Circulation 2005, 11:796-803.
Ramona Scotland, Sharmila Chauhan, Clare Davis, Carmen De Felipe, Stephen Hunt, Jahangir Kabir, Peter Kotsonis & Amrita Ahluwalia. Vanilloid receptor TRPV1, sensory C-fibers, and vascular autoregulation: a novel mechanism involved in myogenic constriction. Circulation Research, 2004, 95:1027-1034.
Andrew J Webb, Richard Bond, Peter McLean, Rakesh Uppal, Nigel Benjamin & Amrita Ahluwalia. Reduction of nitric oxide during ischemia protects against myocardial ischemia-reperfusion damage. PNAS, 2004, 101:13683-13688.
16 November 2015
Amrita Ahluwalia awarded Women in Science and Engineering prize
Professor Amrita Ahluwalia from Queen Mary University of London has been awarded the 2015 Prize for Research by the Wise (Women in Science and Engineering) Campaign.
22 June 2015
Amrita Ahluwalia to become the next Editor-in-Chief of the British Journal of Pharmacology
QMUL is pleased to announce that the next Editor-in-Chief of the British Journal of Pharmacology will be Professor Amrita Ahluwalia, Deputy Director of QMUL's William Harvey Research Institute.
29 June 2010
Nitrate content 'behind benefits of beetroot juice'
29 June 2010
Drinking beetroot juice dramatically lowers risk of heart disease and strokes
Beetroot juice lowers blood pressure
6 February 2008
Beetroot 'may cut blood pressure'
Internal: Adrian Hobbs, (WHRI), Mauro Perretti (WHRI)
External: Mark D Baker (ICMS), Fernand Gobeil, Raymond Macallister
Deputy Director of WHRI / Professor of Vascular Biology
Centre for Clinical Pharmacology
Barts and The London Queen Mary's School of Medicine and Dentistry
John Vane Science Centre
London, EC1M 6BQ
T: +44 20 7882 8377
F: +44 20 7882 3408